These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 17196590)

  • 21. Interactive effects of the mGlu5 receptor antagonist MPEP and the mGlu2/3 receptor antagonist LY341495 on nicotine self-administration and reward deficits associated with nicotine withdrawal in rats.
    Liechti ME; Markou A
    Eur J Pharmacol; 2007 Jan; 554(2-3):164-74. PubMed ID: 17113075
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Group II metabotropic glutamate receptor modulation of DOI-induced c-fos mRNA and excitatory responses in the cerebral cortex.
    Zhai Y; George CA; Zhai J; Nisenbaum ES; Johnson MP; Nisenbaum LK
    Neuropsychopharmacology; 2003 Jan; 28(1):45-52. PubMed ID: 12496939
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The selective mGlu2/3 receptor antagonist LY341495 exacerbates behavioral signs of morphine withdrawal and morphine-withdrawal-induced activation of locus coeruleus neurons.
    Rasmussen K; Hsu MA; Vandergriff J
    Neuropharmacology; 2004 Apr; 46(5):620-8. PubMed ID: 14996539
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The preclinical properties of a novel group II metabotropic glutamate receptor agonist LY379268.
    Imre G
    CNS Drug Rev; 2007; 13(4):444-64. PubMed ID: 18078428
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synthesis, pharmacological characterization, and molecular modeling of heterobicyclic amino acids related to (+)-2-aminobicyclo[3.1.0] hexane-2,6-dicarboxylic acid (LY354740): identification of two new potent, selective, and systemically active agonists for group II metabotropic glutamate receptors.
    Monn JA; Valli MJ; Massey SM; Hansen MM; Kress TJ; Wepsiec JP; Harkness AR; Grutsch JL; Wright RA; Johnson BG; Andis SL; Kingston A; Tomlinson R; Lewis R; Griffey KR; Tizzano JP; Schoepp DD
    J Med Chem; 1999 Mar; 42(6):1027-40. PubMed ID: 10090786
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evidence of anoxia-induced channel arrest in the brain of the goldfish (Carassius auratus).
    Wilkie MP; Pamenter ME; Alkabie S; Carapic D; Shin DS; Buck LT
    Comp Biochem Physiol C Toxicol Pharmacol; 2008 Nov; 148(4):355-62. PubMed ID: 18620076
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Protective role of group-II metabotropic glutamate receptors against nigro-striatal degeneration induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in mice.
    Battaglia G; Busceti CL; Pontarelli F; Biagioni F; Fornai F; Paparelli A; Bruno V; Ruggieri S; Nicoletti F
    Neuropharmacology; 2003 Aug; 45(2):155-66. PubMed ID: 12842121
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [3H]-LY341495 as a novel antagonist radioligand for group II metabotropic glutamate (mGlu) receptors: characterization of binding to membranes of mGlu receptor subtype expressing cells.
    Johnson BG; Wright RA; Arnold MB; Wheeler WJ; Ornstein PL; Schoepp DD
    Neuropharmacology; 1999 Oct; 38(10):1519-29. PubMed ID: 10530814
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characterization of [(3)H]-LY354740 binding to rat mGlu2 and mGlu3 receptors expressed in CHO cells using semliki forest virus vectors.
    Schweitzer C; Kratzeisen C; Adam G; Lundstrom K; Malherbe P; Ohresser S; Stadler H; Wichmann J; Woltering T; Mutel V
    Neuropharmacology; 2000 Jul; 39(10):1700-6. PubMed ID: 10884552
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of LY379268, a selective group II metabotropic glutamate receptor agonist on EEG activity, cortical perfusion, tissue damage, and cortical glutamate, glucose, and lactate levels in brain-injured rats.
    Stover JF; Sakowitz OW; Beyer TF; Dohse NK; Kroppenstedt SN; Thomale UW; Schaser KD; Unterberg AW
    J Neurotrauma; 2003 Apr; 20(4):315-26. PubMed ID: 12866811
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The mGlu2/3 receptor agonist LY379268 injected into cortex or thalamus decreases neuronal injury in retrosplenial cortex produced by NMDA receptor antagonist MK-801: possible implications for psychosis.
    Carter K; Dickerson J; Schoepp DD; Reilly M; Herring N; Williams J; Sallee FR; Sharp JW; Sharp FR
    Neuropharmacology; 2004 Dec; 47(8):1135-45. PubMed ID: 15567423
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Epigenetic modulation of mGlu2 receptors by histone deacetylase inhibitors in the treatment of inflammatory pain.
    Chiechio S; Zammataro M; Morales ME; Busceti CL; Drago F; Gereau RW; Copani A; Nicoletti F
    Mol Pharmacol; 2009 May; 75(5):1014-20. PubMed ID: 19255242
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The relationship between NMDA receptor function and the high ammonia tolerance of anoxia-tolerant goldfish.
    Wilkie MP; Pamenter ME; Duquette S; Dhiyebi H; Sangha N; Skelton G; Smith MD; Buck LT
    J Exp Biol; 2011 Dec; 214(Pt 24):4107-20. PubMed ID: 22116753
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neuroprotective effects of granulocyte colony-stimulating factor on ischemia-reperfusion injury of the retina.
    Shima C; Adachi Y; Minamino K; Okigaki M; Shi M; Imai Y; Yanai S; Takahashi K; Ikehara S
    Ophthalmic Res; 2012; 48(4):199-207. PubMed ID: 22868688
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular signalling mediating the protective effect of A1 adenosine and mGlu3 metabotropic glutamate receptor activation against apoptosis by oxygen/glucose deprivation in cultured astrocytes.
    Ciccarelli R; D'Alimonte I; Ballerini P; D'Auro M; Nargi E; Buccella S; Di Iorio P; Bruno V; Nicoletti F; Caciagli F
    Mol Pharmacol; 2007 May; 71(5):1369-80. PubMed ID: 17293559
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Group II metabotropic glutamate receptor blockade promotes stress resilience in mice.
    Highland JN; Zanos P; Georgiou P; Gould TD
    Neuropsychopharmacology; 2019 Sep; 44(10):1788-1796. PubMed ID: 30939596
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of BDNF/TrkB signaling in antidepressant-like effects of a group II metabotropic glutamate receptor antagonist in animal models of depression.
    Koike H; Fukumoto K; Iijima M; Chaki S
    Behav Brain Res; 2013 Feb; 238():48-52. PubMed ID: 23098797
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neuroprotective effects of LY379268, a selective mGlu2/3 receptor agonist: investigations into possible mechanism of action in vivo.
    Bond A; Jones NM; Hicks CA; Whiffin GM; Ward MA; O'Neill MF; Kingston AE; Monn JA; Ornstein PL; Schoepp DD; Lodge D; O'Neill MJ
    J Pharmacol Exp Ther; 2000 Sep; 294(3):800-9. PubMed ID: 10945827
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Apoptotic cell death in the mouse retinal ganglion cell layer is induced in vivo by the excitatory amino acid homocysteine.
    Moore P; El-sherbeny A; Roon P; Schoenlein PV; Ganapathy V; Smith SB
    Exp Eye Res; 2001 Jul; 73(1):45-57. PubMed ID: 11428862
    [TBL] [Abstract][Full Text] [Related]  

  • 40. HDAC and HAT inhibitors differently affect analgesia mediated by group II metabotropic glutamate receptors.
    Zammataro M; Sortino MA; Parenti C; Gereau RW; Chiechio S
    Mol Pain; 2014 Nov; 10():68. PubMed ID: 25406541
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.